Skip to content

Globus Medical GMED Stock-Based Comp

Stock-Based Comp at other companies

Medtronic logo
MedtronicMDT
Intuitive Surgical logo
Intuitive SurgicalISRG
Solventum logo
SolventumSOLV
Baxter International logo
Baxter InternationalBAX
Nordson logo
NordsonNDSN
GE HealthCare Technologies logo
GE HealthCare TechnologiesGEHC

Other financials

Income statement

See full
Revenue$759.9M+27.0%
Gross profit$525.8M+30.6%
Operating income$150.4M+55.0%
Net income$124.3M+64.7%
EPS (diluted)$0.90+66.7%

Balance sheet

See full
Cash & equivalents$561.0M+21.6%
Total debt$116.3M+25.0%
Total equity$4.7B+15.8%
Total assets$5.4B+15.5%

Cash flow

See full
Operating cash flow$202.4M+14.1%
CapEx$39.6M+9.7%
Free cash flow$162.7M+15.3%

Valuation

See full
Market cap$10.76B+15.7%
Enterprise value$10.31B+15.6%
P/E18.3×-31.7×
P/S3.5×-0.2×

Profitability

See full
Gross margin67.9%+7.3pp
Operating margin17.2%+7.0pp
Net margin18.9%+11.5pp
FCF margin19.7%-1.1pp

Returns & leverage

See full
Return on equity13.3%+8.7pp
Debt / equity0.0×
Current ratio4.6×+0.1×

Where this comes from

Reported directly by Globus Medical in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Globus Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Globus Medical's stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Globus Medical's stock-based comp?
Globus Medical (GMED) reported stock-based comp of $12.62M in Q1 2026.
How has Globus Medical's stock-based comp changed year-over-year?
Globus Medical's stock-based comp decreased by 4.5% year-over-year, from $13.21M to $12.62M.
What is the long-term trend for Globus Medical's stock-based comp?
Over 4 years (2021 to 2025), Globus Medical's stock-based comp has grown at a 12.9% compound annual growth rate (CAGR), from $30.59M to $49.78M.